Marja S.
- Country
- Finland
- Department
- Hematology
Research Overview
- Evaluation of Belantamab Monotherapy and Combination Regimens in Patients with Multiple Myeloma: Safety and Clinical Activity Assessment
- Evaluation of Minimal Residual Disease in Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients Treated with Ixazomib, Lenalidomide, and Dexamethasone
- Phase 3 Open-Label Study of Elranatamab vs. Elotuzumab, Pomalidomide, Dexamethasone, or Carfilzomib in Relapsed/Refractory Multiple Myeloma Post Anti-CD38 Therapy
Data & Insights
Has run more than one trial at 40 of 154 partner sites.
Specializations
Multiple Myeloma Treatment
This investigator specializes in the treatment of multiple myeloma, with particular focus on developing innovative therapeutic approaches for both newly diagnosed and relapsed/refractory cases.
- Novel Combination Therapies
- Monoclonal Antibody Treatment
- Immunotherapy Applications
Their research encompasses various treatment modalities including targeted therapies and immunomodulatory approaches.
Refractory Disease Management
The investigator focuses on addressing relapsed/refractory multiple myeloma, particularly in patients who have received prior anti-CD38 directed therapy.
- Treatment-Resistant Cases
- Alternative Therapy Pathways
- Sequential Treatment Strategies
Their work includes evaluating comparative efficacy of various therapeutic combinations in resistant disease states.
Disease Monitoring and Assessment
The investigator specializes in minimal residual disease assessment and monitoring techniques for multiple myeloma patients.
- Bone Marrow Analysis
- Serological Monitoring
- Treatment Response Evaluation
Their expertise includes advanced diagnostic approaches and treatment response assessment methodologies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.